Ming-Zhong Sun Selected Research

Annexins

1/2018	Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways.
3/2016	ANXA11 regulates the tumorigenesis, lymph node metastasis and 5-fluorouracil sensitivity of murine hepatocarcinoma Hca-P cells by targeting c-Jun.
3/2015	Annexin A11 knockdown inhibits in vitro proliferation and enhances survival of Hca-F cell via Akt2/FoxO1 pathway and MMP-9 expression.
11/2013	Potential role of Anxa1 in cancer.
2/2013	The role of annexin A3 playing in cancers.
9/2012	The association of annexin A2 and cancers.
1/2012	Proteomic research progress in lymphatic metastases of cancers.
10/2008	High-performance liquid chromatography/nano-electrospray ionization tandem mass spectrometry, two-dimensional difference in-gel electrophoresis and gene microarray identification of lymphatic metastasis-associated biomarkers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Zhong Sun Research Topics

Disease

32	Neoplasms (Cancer) 01/2022 - 06/2009
14	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2008
6	Carcinogenesis 01/2021 - 01/2014
6	Lymphatic Metastasis 12/2016 - 10/2008
5	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 10/2008
4	Carcinoma (Carcinomatosis) 01/2020 - 08/2010
3	Hepatocellular Carcinoma (Hepatoma) 07/2020 - 08/2011
2	Ischemia 01/2021 - 04/2009
2	Wounds and Injuries (Trauma) 01/2021 - 10/2009
2	Renal Cell Carcinoma (Grawitz Tumor) 07/2020 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 04/2016
1	Fibrosarcoma 01/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Cognitive Dysfunction 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Kidney Neoplasms (Kidney Cancer) 01/2019
1	Obesity 01/2018
1	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2016
1	Squamous Cell Carcinoma of Head and Neck 07/2015
1	Glioma (Gliomas) 07/2015
1	Autoimmune Diseases (Autoimmune Disease) 03/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2014
1	Chronic Disease (Chronic Diseases) 01/2014
1	Breast Neoplasms (Breast Cancer) 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 01/2014
1	Adenocarcinoma 01/2014
1	Inflammation (Inflammations) 11/2013
1	Burns 09/2012
1	Skin Diseases (Skin Disease) 09/2012

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2008
8	AnnexinsIBA 01/2018 - 10/2008
8	Biomarkers (Surrogate Marker)IBA 01/2015 - 10/2008
6	Cadherins (E-Cadherin)IBA 01/2022 - 10/2009
3	VimentinIBA 01/2022 - 10/2008
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2018
3	Biological ProductsIBA 01/2021 - 08/2011
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2020 - 01/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 08/2010
3	Annexin A5IBA 01/2018 - 01/2014
3	Keratins (Keratin)IBA 01/2015 - 10/2008
2	Long Noncoding RNAIBA 01/2022 - 07/2020
2	Tissue Inhibitor of Metalloproteinase-1IBA 01/2022 - 01/2019
2	Messenger RNA (mRNA)IBA 06/2020 - 10/2008
2	Actins (F Actin)IBA 04/2020 - 02/2013
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2020 - 08/2010
2	alpha-2-HS-GlycoproteinIBA 01/2018 - 04/2016
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2018 - 03/2015
2	CarcinogensIBA 11/2013 - 02/2013
2	Annexin A7 (Synexin)IBA 08/2013 - 06/2009
2	Caveolin 1IBA 06/2012 - 10/2009
2	EnzymesIBA 04/2009 - 08/2006
1	Competitive Endogenous RNAIBA 01/2022
1	MitogensIBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	EpiregulinIBA 01/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	GlycogenIBA 01/2021
1	Taurine FDA Link 01/2021
1	Antisense RNA (Anti-Sense RNA)IBA 07/2020
1	InterferonsIBA 06/2020
1	RetinoidsIBA 06/2020
1	ChromatinIBA 04/2020
1	CalciumIBA 01/2018
1	IntegrinsIBA 01/2018
1	C-Reactive ProteinIBA 04/2016
1	Fluorouracil (Carac)FDA LinkGeneric 03/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Annexin A6IBA 10/2015
1	Interleukin-18 (Interleukin 18)IBA 09/2015
1	Immunoglobulin G (IgG)IBA 09/2015
1	Angiogenesis InhibitorsIBA 09/2015
1	Annexin A4IBA 07/2015
1	Cisplatin (Platino)FDA LinkGeneric 07/2015
1	Carrier Proteins (Binding Protein)IBA 03/2015
1	Tumor Biomarkers (Tumor Markers)IBA 01/2015
1	AntigensIBA 01/2015
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2015
1	Phosphotransferases (Kinase)IBA 12/2014
1	Mitogen-Activated Protein KinasesIBA 04/2014
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2014
1	Galectin 3 (LGALS3)IBA 04/2014
1	FlavonoidsIBA 01/2014
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 03/2013
1	Environmental BiomarkersIBA 02/2013
1	Annexin A3IBA 02/2013
1	Cathepsin DIBA 09/2012
1	PeroxiredoxinsIBA 09/2012
1	Laminin ReceptorsIBA 09/2012
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 09/2012
1	Annexin A2 (Annexin II)IBA 09/2012

Therapy/Procedure

1	Therapeutics 01/2022
1	Hepatectomy 01/2021
1	Radiotherapy 01/2019
1	Drug Therapy (Chemotherapy) 01/2019
1	Intraperitoneal Injections 09/2015